Sage Journals: Discover world-class research

Retricted access

Research article

First published 2007-06

Patient-Specific Vaccines Derived from Autologous Tumor Cell Lines as Active Specific Immunotherapy: Results of Exploratory Phase I/II Trials in Patients with Metastatic Melanoma

Robert O. Dillman, Carol DePriest, Cristina DeLeon [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2000-04

Short-Term Tumor Cell Lines from Renal Cell Carcinoma for Use as Autologous Tumor Cell Vaccines in the Treatment of Kidney Cancer

Robert O. Dillman, Linda D. Beutel, Andrew N. Cornforth [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2001-06

Short-Term Tumor Cell Lines from Breast Cancer for Use as Autologous Tumor Cell Vaccines in the Treatment of Breast Cancer

Robert O. Dillman, Linda D. Beutel, Cristina De Leon [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 1999-08

A Universal Granulocyte-Macrophage Colony-Stimulating Factor-Producing Bystander Cell Line for Use in the Formulation of Autologous Tumor Cell-Based Vaccines

Ivan Borrello, Eduardo M. Sotomayor, Sara Cooke [...]

Human Gene Therapy

Retricted access

Research article

First published 2001-02

Treatment of Kidney Cancer with Autologous Tumor Cell Vaccines of Short-Term Cell Lines Derived from Renal Cell Carcinoma

Robert O. Dillman, Neil M. Barth, Louis A. VanderMolen [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2004-10

Phase I/II Trial of Autologous Tumor Cell Line–Derived Vaccines for Recurrent or Metastatic Sarcomas

Robert Dillman, Neil Barth, Senthamil Selvan [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2002-02

Irradiated Cells from Autologous Tumor Cell Lines as Patient-Specific Vaccine Therapy in 125 Patients with Metastatic Cancer: Induction of Delayed-Type Hypersensitivity to Autologous Tumor is Associated with Improved Survival

Robert O. Dillman, Linda D. Beutel, Neil M. Barth [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 1998-06

Clinical Experience with Autologous Tumor Cell Lines for Patient-Specific Vaccine Therapy in Metastatic Melanoma

Robert O. Dillman, Shankar K. Nayak, Neil M. Barth [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2004-10

Autologous Tumor Cell Line–Derived Vaccine for Patient-Specific Treatment of Advanced Renal Cell Carcinoma

Robert Dillman, Neil Barth, Louis VanderMolen [...]

Cancer Biotherapy and Radiopharmaceuticals

Open access

Research article

First published 2014-03

High-Dose IL2 in Metastatic Melanoma: Better Survival in Patients Immunized with Antigens from Autologous Tumor Cell Lines

Robert O. Dillman, Carol DePriest, Stephanie E. McClure

Cancer Biotherapy and Radiopharmaceuticals

Search results